Novavax

American biotechnology company

Novavax ▸ Facts ▸ Comments ▸ News ▸ Videos

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for influenza and respiratory syncytial virus (RSV), as well as Ebola and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its NVX-CoV2373 vaccine for COVID-19.

0 shares	Share Tweet Save Post Send

You Might Like

WHO approves SII's Covovax for emergency use Covavax is the Indian version of the Novavax vaccine brought in India by the Serum Institute of India for children. DNA - Published on December 17, 2021
Novavax Covid-19 vaccine receives first emergency use authorization Novavax Inc and partner Serum Institute of India said on Monday they received emergency use authorization for their Covid-19 vaccine in Indonesia, making it the first approval anywhere in the world for.. IndiaTimes - Published on November 1, 2021
Novavax trials to include kids from 7 to 11 IndiaTimes - Published on September 29, 2021